Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesar Ochoa

Showing results (11-20 of 33) with videos related to

Pageof 4
Sort By:
Australasian Physical & Engineering Sciences in Medicine|November 1, 2017
Investigating the impact of treatment delivery uncertainties on treatment effectiveness for lung SABRSamuel J Blake, Sankar Arumugam, Lois Holloway, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 9, 2023
An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE studyPamela Ventola, Judith Jaeger, Christopher J Keary, et al.
The British Journal of Radiology|June 10, 2020
Impact of dosimetric differences between CT and MRI derived target volumes for external beam cervical cancer radiotherapyVikneswary Batumalai, Siobhan Burke, Dale Roach, et al.
Diabetes|January 31, 2006
Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetesAnny H Xiang, Ruth K Peters, Siri L Kjos, et al.
Diabetes Care|May 27, 2004
Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) studySoren Snitker, Richard M Watanabe, Ifeanyi Ani, et al.
Recent Patents on Anti-Infective Drug Discovery|June 14, 2016
Complement 3 Receptor Expression in Individuals with Type 2 DiabetesJudy Ly, Devin Morris, Minette Lagman, et al.
Plos One|March 20, 2015
Investigating the causes for decreased levels of glutathione in individuals with type II diabetesMinette Lagman, Judy Ly, Tommy Saing, et al.
BMJ Open Diabetes Research & Care|August 2, 2017
Standardized screening for periodontitis as an integral part of multidisciplinary management of adults with type 2 diabetes: an observational cross-sectional study of cohorts in the USA and UKAndrew S Pumerantz, Susan M Bissett, Fanglong Dong, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 3, 2015
Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected IndividualsJudy Ly, Minette Lagman, Tommy Saing, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell functionAnny H Xiang, Ruth K Peters, Siri L Kjos, et al.
Pageof 4

Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Australasian Physical & Engineering Sciences in Medicine|November 1, 2017
Investigating the impact of treatment delivery uncertainties on treatment effectiveness for lung SABRSamuel J Blake, Sankar Arumugam, Lois Holloway, et al.
European Journal of Paediatric Neurology : EJPN : Official Journal of the European Paediatric Neurology Society|September 9, 2023
An adapted clinical global Impression of improvement for use in Angelman syndrome: Validation analyses utilizing data from the NEPTUNE studyPamela Ventola, Judith Jaeger, Christopher J Keary, et al.
The British Journal of Radiology|June 10, 2020
Impact of dosimetric differences between CT and MRI derived target volumes for external beam cervical cancer radiotherapyVikneswary Batumalai, Siobhan Burke, Dale Roach, et al.
Diabetes|January 31, 2006
Effect of pioglitazone on pancreatic beta-cell function and diabetes risk in Hispanic women with prior gestational diabetesAnny H Xiang, Ruth K Peters, Siri L Kjos, et al.
Diabetes Care|May 27, 2004
Changes in insulin sensitivity in response to troglitazone do not differ between subjects with and without the common, functional Pro12Ala peroxisome proliferator-activated receptor-gamma2 gene variant: results from the Troglitazone in Prevention of Diabetes (TRIPOD) studySoren Snitker, Richard M Watanabe, Ifeanyi Ani, et al.
Recent Patents on Anti-Infective Drug Discovery|June 14, 2016
Complement 3 Receptor Expression in Individuals with Type 2 DiabetesJudy Ly, Devin Morris, Minette Lagman, et al.
Plos One|March 20, 2015
Investigating the causes for decreased levels of glutathione in individuals with type II diabetesMinette Lagman, Judy Ly, Tommy Saing, et al.
BMJ Open Diabetes Research & Care|August 2, 2017
Standardized screening for periodontitis as an integral part of multidisciplinary management of adults with type 2 diabetes: an observational cross-sectional study of cohorts in the USA and UKAndrew S Pumerantz, Susan M Bissett, Fanglong Dong, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 3, 2015
Liposomal Glutathione Supplementation Restores TH1 Cytokine Response to Mycobacterium tuberculosis Infection in HIV-Infected IndividualsJudy Ly, Minette Lagman, Tommy Saing, et al.
The Journal of Clinical Endocrinology and Metabolism|June 8, 2004
Pharmacological treatment of insulin resistance at two different stages in the evolution of type 2 diabetes: impact on glucose tolerance and beta-cell functionAnny H Xiang, Ruth K Peters, Siri L Kjos, et al.
Pageof 4